PDCD1/PD1/CD279 (Budigalimab biosimilar) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-PDCD1/PD1/CD279 (Budigalimab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityPDCD1/PD1/CD279 (Budigalimab biosimilar)
Clonemonoclonal
Host SpeciesRecombinant Human
Reactive Specieshuman
IsotypeIgG1 kappa
FormatProtein A/G purified
Size100 µg, 1 mg,
Concentrationtypically between 0.5-2.0 mg/ml.
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionBudigalimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Immunogenn/a
Other NamesBudigalimab, PDCD1/PD1/CD279, 2098225-93-3
Gene, Accession #CAS: 2098225-93-3
Catalog #abx831483
Priceplease inquire
Order / More InfoPDCD1/PD1/CD279 (Budigalimab biosimilar) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.